Agilent Technologies, Inc. (A) Shares Sold by Signature Estate & Investment Advisors LLC
Signature Estate & Investment Advisors LLC reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 0.2% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,300 shares of the medical research company’s stock after selling 21 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in Agilent Technologies were worth $552,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of A. Jennison Associates LLC bought a new position in Agilent Technologies in the 2nd quarter valued at approximately $212,000. Commerce Bank bought a new position in Agilent Technologies in the 2nd quarter valued at approximately $1,242,000. Skandinaviska Enskilda Banken AB publ raised its holdings in Agilent Technologies by 5.7% in the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock valued at $3,428,000 after buying an additional 3,489 shares during the last quarter. Delta Lloyd Asset Management N.V. bought a new position in Agilent Technologies in the 2nd quarter valued at approximately $2,026,000. Finally, Prudential Financial Inc. raised its holdings in Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock valued at $27,134,000 after buying an additional 11,020 shares during the last quarter.
In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total value of $79,200.00. Following the completion of the sale, the chief financial officer now owns 164,202 shares in the company, valued at $10,837,332. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 16,492 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $65.33, for a total value of $1,077,422.36. Following the completion of the sale, the chief executive officer now owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. Insiders sold 170,720 shares of company stock valued at $10,795,039 in the last quarter.
A number of brokerages recently issued reports on A. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and issued a $68.00 price objective on shares of Agilent Technologies in a report on Tuesday. Cowen and Company reiterated a “hold” rating and issued a $65.00 price objective on shares of Agilent Technologies in a report on Thursday. Bank of America Corporation raised their price objective on shares of Agilent Technologies from $66.00 to $68.00 and gave the company an “equal weight” rating in a report on Wednesday, August 16th. Barclays PLC reiterated a “buy” rating and issued a $67.00 price objective on shares of Agilent Technologies in a report on Wednesday, July 19th. Finally, Wells Fargo & Company upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $42.92 to $60.73 in a report on Wednesday, July 12th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and a consensus price target of $64.38.
Agilent Technologies, Inc. (A) traded up 0.34% on Friday, reaching $64.20. 1,672,816 shares of the company’s stock traded hands. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $66.45. The firm’s 50-day moving average is $62.75 and its 200 day moving average is $58.31. The firm has a market cap of $20.66 billion, a PE ratio of 33.11 and a beta of 1.30.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. Equities analysts predict that Agilent Technologies, Inc. will post $2.32 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be given a $0.132 dividend. The ex-dividend date is Monday, October 2nd. This represents a $0.53 annualized dividend and a yield of 0.82%. Agilent Technologies’s payout ratio is currently 27.32%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.